Consider Recommending a Beta-Blocker for Surgery in High-Risk Patients

October 2014

New guidelines will clarify when to use beta-blockers for noncardiac surgery.

Beta-blockers reduce nonfatal MI risk in high-risk patients undergoing noncardiac surgery...probably by decreasing cardiac workload.

But this benefit can come at a cost...bradycardia, hypotension, and possibly a higher risk of stroke and death.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote